Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M87,649Revenue $M19,959Net Margin (%)12.1Altman Z-Score4.1
Enterprise Value $M91,428EPS $2.2Operating Margin %20.3Piotroski F-Score5
P/E(ttm)33.6Beneish M-Score-2.5Pre-tax Margin (%)14.0Higher ROA y-yN
Price/Book5.510-y EBITDA Growth Rate %10.8Quick Ratio1.1Cash flow > EarningsY
Price/Sales4.05-y EBITDA Growth Rate %-6.0Current Ratio1.5Lower Leverage y-yN
Price/Free Cash Flow50.5y-y EBITDA Growth Rate %-9.4ROA % (ttm)8.0Higher Current Ratio y-yN
Dividend Yield %2.7PEG--ROE % (ttm)18.6Less Shares Outstanding y-yY
Payout Ratio %90.0Shares Outstanding M1,108ROIC % (ttm)21.7Gross Margin Increase y-yY

Gurus Latest Trades with LLY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
LLYVanguard Health Care Fund 2015-12-31 Add0.13%$76.98 - $87.52
($83.01)
$ 74.32-10%Add 3.16%24,609,530
LLYKen Fisher 2015-12-31 Add0.04%$76.98 - $87.52
($82.95)
$ 74.32-10%Add 18.78%1,472,117
LLYMario Gabelli 2015-12-31 Reduce-0.01%$76.98 - $87.52
($83.01)
$ 74.32-10%Reduce -13.84%84,350
LLYHOTCHKIS & WILEY 2015-09-30 Reduce-1.13%$78.26 - $89.98
($84.37)
$ 74.32-12%Reduce -99.30%26,900
LLYVanguard Health Care Fund 2015-09-30 Reduce-0.26%$78.26 - $89.98
($84.37)
$ 74.32-12%Reduce -5.99%23,854,960
LLYKen Fisher 2015-09-30 Add0.04%$78.26 - $89.98
($84.37)
$ 74.32-12%Add 20.44%1,239,408
LLYDodge & Cox 2015-09-30 Reduce$78.26 - $89.98
($84.37)
$ 74.32-12%Reduce -3.06%31,634
LLYCharles Brandes 2015-06-30 Sold Out -0.11%$70.89 - $86.59
($76.14)
$ 74.32-2%Sold Out0
LLYVanguard Health Care Fund 2015-06-30 Add0.08%$70.89 - $86.59
($76.14)
$ 74.32-2%Add 1.94%25,375,160
LLYKen Fisher 2015-06-30 Add0.04%$70.89 - $86.59
($76.14)
$ 74.32-2%Add 29.29%1,029,030
LLYHOTCHKIS & WILEY 2015-06-30 Reduce-0.03%$70.89 - $86.59
($76.14)
$ 74.32-2%Reduce -2.52%3,868,109
LLYDodge & Cox 2015-06-30 Reduce$70.89 - $86.59
($76.14)
$ 74.32-2%Reduce -9.94%32,634
LLYMario Gabelli 2015-06-30 Reduce$70.89 - $86.59
($76.14)
$ 74.32-2%Reduce -12.43%97,900
LLYVanguard Health Care Fund 2015-03-31 Add0.45%$68.41 - $76.36
($71.19)
$ 74.324%Add 13.24%24,892,160
LLYCharles Brandes 2015-03-31 Reduce-0.06%$68.41 - $76.36
($71.19)
$ 74.324%Reduce -36.80%107,025
LLYKen Fisher 2015-03-31 Add0.03%$68.41 - $76.36
($71.19)
$ 74.324%Add 37.46%795,909
LLYHOTCHKIS & WILEY 2015-03-31 Add0.01%$68.41 - $76.36
($71.19)
$ 74.324%Add 0.70%3,968,039
LLYJoel Greenblatt 2015-03-31 Sold Out -0.0031%$68.41 - $76.36
($71.19)
$ 74.324%Sold Out0
LLYMario Gabelli 2015-03-31 Reduce$68.41 - $76.36
($71.19)
$ 74.324%Reduce -1.76%111,800
LLYDodge & Cox 2015-03-31 Reduce$68.41 - $76.36
($71.19)
$ 74.324%Reduce -7.10%36,234
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LLY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


LLY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ricks David ASVP and Pres, Lilly Bio-Meds 2016-02-03Sell5,733$77.66-4.3view
Rice Derica WEVP-Global Services and CFO 2016-02-03Sell10,483$77.78-4.45view
Fry Stephen FSVP, HR & Diversity 2016-02-03Sell3,137$77.94-4.64view
TAI JACKSON PDirector 2016-02-01Buy3,170$78.62-5.47view
Zulueta Alfonso GSVP& Pres., Emerging Markets 2016-01-29Sell5,000$78.75-5.63view
LILLY ENDOWMENT INC10% Owner 2015-12-21Sell205,000$86-13.58view
LILLY ENDOWMENT INC10% Owner 2015-12-15Sell215,000$85.6-13.18view
Conterno Enrique ASr. VP & Pres., Lilly Diabetes 2015-12-09Sell25,000$83.88-11.4view
LILLY ENDOWMENT INC10% Owner 2015-12-02Sell210,000$85.09-12.66view
LILLY ENDOWMENT INC10% Owner 2015-11-20Sell205,000$84.54-12.09view

Quarterly/Annual Reports about LLY:

    News about LLY:

    Articles On GuruFocus.com
    Steven Cohen Makes Eli Lilly, Kraft Heinz, American Axle and Airgas 3rd Quarter New Buys Jan 07 2016 
    Mairs and Power Sells Baxalta, Walt Disney, Target Dec 16 2015 
    HOTCHKIS & WILEY Buys More Than 7 Million Shares in Oil and Gas Company Dec 02 2015 
    John Hussman Buys, Sells Most Valuable Stakes in Second Quarter Aug 04 2015 
    Weekly 52-Week Highs Highlight: LLY, PLL, SBUX, VLO Jul 07 2015 
    Bristol-Myers Squibb Takes A Step Up On Cancer Drugs, But The Cost Tells A Different Story Jun 22 2015 
    Activist Hedge Fund Manager Has Strong Focus on Health Care Stocks Jun 11 2015 
    Abbvie Inc. Dividend Stock Analysis May 26 2015 
    Biogen Making A Breakthrough In Treating Alzheimer’s May 02 2015 
    MannKind Looks Good For Long Term Investors Apr 29 2015 

    More From Other Websites
    String of Q4 Earnings Beat Fails to Revive Pharma ETFs Feb 05 2016
    Growth, Factors at Play - Analyst Notes on General Electric, Dow Chemical, Bristol-Myers Squibb and... Feb 04 2016
    Indiana culture war over gay rights worries business leaders Feb 03 2016
    Indiana culture war over gay rights worries business leaders Feb 03 2016
    Merck Stock Slides As Q4 Revenue, Guidance Miss Expectations Feb 03 2016
    American Diabetes Association® Survey Shows Summer Camp Can Positively Impact Children's Disease... Feb 03 2016
    Eli Lilly and Co.’s 4Q15 Earnings: An Overview Feb 03 2016
    Indiana business fears fallout from gay rights failure Feb 03 2016
    Indiana business fears fallout from gay rights failure Feb 03 2016
    Pfizer Looks Undervalued Feb 02 2016
    Wall Street Is as Bearish as 2009: 4 Top Dividend Stocks to Buy Right Now Feb 02 2016
    Credit Suisse Picks 7 Health Care Stocks to Own for the Next 6 Months Feb 02 2016
    Jim Cramer's Long-Term View on Health Care Stocks Feb 01 2016
    Technical Pointers on Drug Manufacturers - Major Stocks -- Bristol-Myers Squibb, Eli Lilly,... Feb 01 2016
    Elanco Contributed ~15% of Total Revenues for Eli Lilly Feb 01 2016
    China’s diabetes boom promises $23 billion pot for drug makers Jan 30 2016
    4Q15 Estimates: Will the Human Pharmaceutical Segment Recover? Jan 29 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK